QR kód

LONG-TERM EFFECTIVENESS AND SAFETY OF LUSPATERCEPT FOR ANEMIA TREATMENT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Introduction: Erythropoiesis-stimulating agents (ESA) are the primary treatment for anemia in most patients with low to moderate-risk myelodysplastic syndromes. However, in some patients, ESA therapy is not effective, and emerging evidence suggests that Luspatercept may offer longstanding benefits i...

Celý popis

Uloženo v:
Hlavní autoři: DVS Cavalcante, IQC Neto, IO Môro, RGO Galvão, JF Abreu, AM Cavalcante, MCFLC Freitas, V Lopes, BX Mendes, FD Xavier
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2024-10-01
Edice:Hematology, Transfusion and Cell Therapy
On-line přístup:http://www.sciencedirect.com/science/article/pii/S253113792401085X
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky